Caroline Duley

发表

Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab

Dawn B. Beaulieu, D. Schwartz, Leyla J. Ghazi, 2016, Inflammatory bowel diseases.

Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing

Dawn B. Beaulieu, D. Schwartz, A. Herline, 2015, Inflammatory bowel diseases.

Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease

Dawn B. Beaulieu, D. Schwartz, Robin L. Dalal, 2017, Digestive Diseases and Sciences.

A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease

Elizabeth A. Scoville, Dawn B. Beaulieu, D. Schwartz, 2020, Crohn's & colitis 360.

The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's Disease.

Elizabeth A. Scoville, Dawn B. Beaulieu, Alexander P. Mamunes, 2021, Inflammatory bowel diseases.

Mo1376 Depression and the Cost of Outpatient Treatment of Crohn's Disease in an US Academic Medical Center

D. Schwartz, R. Stiles, I. Ray, 2013 .

W1315 Re-Capturing Response With Micro-Reinduction of Adalimumab: A Tertiary Care Center Experience

D. Schwartz, A. Ananthakrishnan, J. Slaughter, 2010 .

Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments

Dawn B. Beaulieu, D. Schwartz, Scott A. Merkley, 2015, Inflammatory bowel diseases.

Treatment with Immunosuppressive Therapy May Improve Depressive Symptoms in Patients with Inflammatory Bowel Disease

Dawn B. Beaulieu, W. Taylor, D. Schwartz, 2015, Digestive Diseases and Sciences.

Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease.

Elizabeth A. Scoville, Dawn B. Beaulieu, D. Schwartz, 2019, Inflammatory bowel diseases.

Mo1867 – The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn’s Disease

Elizabeth A. Scoville, Dawn B. Beaulieu, D. Schwartz, 2019, Gastroenterology.

Depression and Inflammatory Bowel Disease Patients: A Tertiary Care Center Experience

Dawn B. Beaulieu, D. Schwartz, S. Horst, 2011 .

Efficacy of and Factors Contributing to Dose Adjustment in Treatment with Certolizumab for Crohnʼs Disease: 1681

Dawn B. Beaulieu, D. Schwartz, S. Horst, 2012 .

Adalimumab and Certolizumab Pegol for the Treatment of Crohn's Disease: Does BMI Make a Difference?

Dawn B. Beaulieu, D. Schwartz, S. Horst, 2011 .